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ABSTRACT: 
Purpose: The aim of this study was to determine a sequence of structural 
changes in Acute Posterior Multifocal Placoid Pigment Epitheliopathy (APMPPE) 
using optical coherence tomography-Angiography (OCT-A) and comparing with 
other imaging modalities. 
Methods: Patients with a new diagnosis of acute onset APMPPE referred to a 
regional specialist centre from October 2015 to October 2016 were included. 
Multimodal imaging employed on all patients from diagnosis included: fundus 
fluorescein angiography, indocyanine green angiography, fundus 
autofluorescence, spectral domain-OCT (SD-OCT) and OCT-A. All non-invasive 
imaging was repeated during follow-up. 
Results: Ten eyes of 5 patients were included in the study, 3 males and 2 
females, with a mean age of 26.2 years (range: 21-32) and a mean follow-up of 
6.4 months (range: 2.6-13.3). All patients presented with bilateral disease and 
macular involving lesions. OCT-A imaging of the choriocapillaris was supportive 
of hypoperfusion at the site of APMPPE lesions during the acute phase of this 
condition with normalisation of choroidal vasculature during follow-up. 
Multimodal imaging consistently highlighted four sequential phases from 
presentation to resolution of active disease. 
Conclusions: Multimodal imaging in patients with APMPPE in acute and long 
term follow-up demonstrates a reversible choroidal hypoperfusion supporting 
the primary inciting pathology as a choriocapillaritis. The evolution shows 
resolution of the ischaemia through a defined sequence that results in persistent 
changes at the level of the retinal pigment epithelium and outer retina. OCT-A 
  
was able to detect pre-clinical changes and chart resolution at the level of the 
choriocapillaris. 
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INTRODUCTION: 
 
Acute posterior multifocal placoid pigment epitheliopathy (APMPPE) is an 
uncommon inflammatory condition that generally affects young healthy adults 
who present with transient acute central or paracentral vision loss related to 
multiple yellow creamy deep placoid lesions. 1 Since the initial description of the 
disease by Gass in 1968 there has been a significant advance in our 
understanding of this disease. 1 Debate persists as to the exact sequence of 
events in the aetiopathogenesis of APMPPE. 2-4 The prevailing view has been that 
the primary insult is most likely to occur at the level of the inner 
choroid/choriocapillaris with retinal changes occurring secondary to this, 5-9 
however definitive proof of this remains elusive. These discussions have also 
been extended to the nomenclature of the disease, with some authors advocating 
for a change in the current name to choroidopathy rather than epitheliopathy.10, 
11 
 
Previous studies have described the evolution of lesions in small case series 
using spectral domain-optical coherence tomography (SD-OCT) 12-14 and fundus 
autofluorescence (FAF), 12, 13, 15 and more recently OCT-Angiography (OCT-A), 5, 9, 
16-18 however the appearance and evolution of the lesions in different imaging 
modalities at the same stage of the disease has not been extensively studied. The 
aim of this study is to describe the sequential evolution of APMPPE lesions based 
on data acquired over the course of patient follow-up using OCT-A and 
correlating this with other imaging modalities. 
  
 
MATERIAL AND METHODS: 
 
Consecutive patients with an acute presentation of APMPPE diagnosed at the 
Regional Ocular Inflammatory Service at the Bristol Eye Hospital, Bristol (UK), 
from October 2015 to October 2016 were included in this retrospective case 
series. All patients had been clinically evaluated using multimodal imaging, 
including combined fundus fluorescein angiography (FFA) and indocyanine 
green angiography (ICGA), fundus autofluorescence (FAF) (Spectralis HRA+OCT, 
Heidelberg Engineering, Heidelberg, Germany), SD-OCT and OCT-A (AngioVue; 
Optovue Inc., Fremont, California, USA) at presentation and during the follow-up. 
 
APMPPE was diagnosed based on the phenotypic appearance of yellow creamy 
deep retinal placoid lesions with the classic pattern of early hypofluorescence 
and late hyperfluorescence on the FFA and persistent hypocyanescence on ICGA 
through all the time frames, regardless the clinical course after initial 
presentation. Data collected included demographics, concomitant symptoms 
(such as headache or viral prodrome), visual acuity (at baseline and at the end of 
follow-up), recurrence of lesions (for each eye), and duration of follow-up. 
 
All patients were treated with a tapering regimen of systemic corticosteroids 
(1mg/Kg) and had extensive work-up to rule out other pathologies that could 
mimic APMPPE, including infectious diseases. This included a QuantiFERON-TB 
Gold test, serology for Syphilis, serum angiotensin-converting enzyme, complete 
blood count, and systemic inflammatory markers. 
  
 
RESULTS: 
 
Ten eyes of 5 patients (3 males, 2 females) were included in the study with a 
mean age of 26.2 years (range: 21-32). All patients presented with bilateral 
ocular disease and had associated severe headache at presentation following a 
coryzal-like illness for approximately 1 week prior to presentation with visual 
symptoms. All patients presented to the uveitis clinic within 1 week of onset of 
visual symptoms. The symptom of headache disappeared after steroid treatment 
in all cases except in Patient 4 who was found to have associated central nervous 
system (CNS) vasculitis with a small focus of high signal in the left corona radiata 
detected on gadolinium-enhanced Magnetic Resonance Imaging of the brain. 
This patient also had an episode of Erythema Nodosum develop a few days prior 
to the development of ophthalmic symptoms coupled with evidence of systemic 
inflammation with an elevated C-reactive protein (46 mg/L). Extensive work-up 
was carried out by the neurology team to exclude an underlying cause for her 
neuro-radiological findings. This included lumbar puncture for microbiology and 
oligoclonal bands which all returned normal/negative results. Of the 3 other 
patients who had neuro-imaging performed, no abnormalities were detected. 
Three out of 5 patients (4 eyes) developed new fundus lesions during the follow-
up, and in one of these the new lesions appeared in both eyes while on systemic 
treatment with prednisolone at dose of 30 mg (Patient 3) once daily. The mean 
duration for which follow-up data was available was 6.4 months (range: 2.6-
13.3). Table 1 summarizes the demographic and clinical data for our cohort. 
 
  
Fluorescein and Indocyanine green angiography: 
All patients had the classic FFA and ICGA findings of APMPPE at presentation as 
described above. Some of the lesions evident on the ICGA were not visible in the 
late frames of the FFA and 4 patients had significant peripheral choroidal disease 
on ICGA which was not visible at any time point on FFA (Figure 1A-D and 2A-D). 
 
Spectral domain optical coherence tomography: 
In all cases abnormalities in the SD-OCT were detected at some stage during 
lesion evolution. Where patients were imaged early in the course of disease the 
SD-OCT may appear qualitatively normal in regions that subsequently become 
abnormal (Figure 3). The earliest abnormalities detected were subtle 
irregularities in the inner segment ellipsoid (ISe) layer and retinal pigment 
epithelium (RPE) with associated loss of the hyporeflective space normally 
visualised between these layers on SD-OCT. The latter change tended to be 
observed primarily in the central macula where this space is more readily 
identifiable in healthy controls. As lesions became more established and/or 
larger, focal areas of hyper-reflectivity also developed in the outer retina, 
primarily localising to the outer nuclear layer (ONL) but also being seen at the 
level of the outer plexiform layer. An intra-retinal cyst was noted at the level of 
the ONL in one eye. SD-OCT also revealed areas of possible focal sub-retinal fluid 
in association with larger APMPPE lesions at baseline. In lesions that had become 
established and failed to completely resolve, there was evidence of persistent 
disruption and/or irregularity of the RPE and associated retinal thinning during 
follow-up. In other, usually smaller lesions, improvement and almost complete 
  
resolution of the detectable abnormalities in the ISe and external limiting 
membrane (ELM) were observed (Figure 2 G1-3 and H1-3). 
 
Fundus autofluorescence: 
The pattern of FAF change was heterogeneous, particularly early in the course of 
lesion evolution. Hypoautofluorescent lesions were detected in the active stage 
of the disease in all patients. These often had an area of relative 
hyperautofluorescence along their edge. Over time there was a progressive 
increase in the autofluorescence signal leading to predominantly 
hyperautofluorescence in the centre of the lesion, but this became more 
generalised and extended to the periphery of the lesion during follow-up. With 
time this hyperautofluorescent signal became less uniform and the lesion 
acquired a speckled appearance. This ultimately led to hypoautofluorescence 
(Figure 2 and 3) consistent with localised atrophy of the RPE centrally 
(corresponding to fundal findings) but often hyperautofluorescence was 
maintained at the edge of the lesion. Individual FAF lesion area may be larger at 
follow-up than the area of lesions identified on FFA/ICG at baseline. 
 
Optical coherence tomography angiography: 
There was evidence of significant hypoperfusion at the level of the 
choriocapillaris in all active lesions of all patients at baseline. Progressive 
reperfusion of the choriocapillaris led to marked improvement, including 
complete resolution, of hypoperfusion in many lesions as detected on choroidal 
OCT-A (Figure 2 and 3).In 3 cases (see below) OCT-A abnormalities developed 
after normalisation following the initial onset of APMPPE. Of note, in all cases 
  
OCT-A revealed an area of relative hyper-reflectivity along the outer border of 
the region of choriocapillaris hypoperfusion. Furthermore, comparing the SD-
OCT B-scan with the en-face OCT-A image it appears that the area of 
hypoperfusion extends beyond the limit of the abnormalities identified on the 
SD-OCT B-scan image at the level of the outer retina (Figure 4). Longitudinal 
follow-up of lesions revealed that both the outer retinal layers and the 
choriocapillaris normalise centripetally from the outer edge of the APMPPE 
lesion, but that the “leading edge” of recovery of the retinal layers appears to 
precede that of the choriocapilliaris throughout follow-up. New lesions in the 
OCT-A were visible in 2 of the patients (Patient 2 and Patient 3) that relapsed 
without new symptoms. These were evident on FAF and SD-OCT also. In one 
other patient (Patient 1) an OCT-A lesion actually occurred months after the 
initial presentation and interestingly this lesion developed in the same area as a 
previous sub-clinical lesion that had been visualised only on OCT-A.  
 
Proposed phases of APMPPE lesions by multimodal imaging: 
Based on the characteristics of each imaging modality at each stage in the 
evolution of the lesion we were able to define 4 distinct consecutive phases: 
- Phase 1- Choroidal: Choriocapillaris hypoperfusion detected with 
OCT-A and confirmed with ICGA and an early FFA phenotype. Both SD-OCT and 
FAF are normal. These lesions can evolve resulting in complete resolution of the 
choriocapillaris abnormalities as detected with OCT-A and without any 
structural changes developing on FAF or SD-OCT (Figure 1), or they evolve to 
phase 2 lesions (see below) (Figure 3). 
  
- Phase 2- Chorioretinal: Evidence of classic active lesion on FFA with 
early hypofluorescence and late hyperfluorescence, persistent hypocyanescence 
of lesions across ICGA frames and choroidal hypoperfusion on OCT-A. Loss of 
structural integrity and hyper-reflectivity of the outer retinal layers including 
RPE, ISe layer and ELM were detected on SD-OCT and predominant 
hypoautofluorescent of APMPPE lesions noted on FAF (Figure 2). 
- Phase 3- Transitional: Thinning and disruption of outer retinal layers 
revealed on SD-OCT with persistent hypoperfusion of the choriocapillaris 
observed on OCT-A, and progressive central hyperautofluorescence observed on 
FAF (Figure 2). 
- Phase 4- Resolution: Persistent thinning of the outer retina visible on 
SD-OCT with hyporeflectivity at the level of the RPE and predominantly 
hypoautofluorescent changes visible on FAF, but with a normalised 
choriocapillaris vascular pattern on OCT-A (Figure 2). 
 
DISCUSSION: 
 
Multimodal imaging provides valuable information and enhanced understanding 
of the progression of APMPPE through to clinical resolution. In our series there 
was a pattern of evolution of the APMPPE lesions with a clear sequence of 
structural changes from presentation to resolution employing multimodal 
imaging. The combination of OCT-A, SD-OCT and FAF imaging has the advantage 
of providing clinical information without the need to use invasive injection of 
contrast dyes. As such, these investigations are more readily repeatable during 
the course of follow-up of APMPPE. Additional work is certainly required to 
  
validate the use of OCT-A in APMPPE if this is to replace conventional 
angiography in diagnosis and management.16 
 
Our findings support the possibility that choriocapillaris hypoperfusion is the 
primary event in the pathogenesis of APMPPE, with RPE and outer retinal 
pathology developing secondary to the localised hypoperfusion resulting from 
this inner choroidal change. This is supported by the fact that lesions in the 
choroidal phase can resolve without leaving structural changes at the level of 
RPE and the area of hypoperfusion at the level of the choriocapillaris appears 
larger than the area of outer retina disruption on the SD-OCT, as it is clearly 
showed in the Figure 4. A similar finding has recently been reported by 
Heiferman et al. 18 In fact these findings, also supports that the presumed 
hypoperfusion in the OCT-A at the level of the choriocapillaris is not due to 
shadowing from the hyper-reflectivity of the overlying retina. The hyper-
reflectivity identified on OCT-A along the border of the area of hypoperfusion 
within the choriocapillaris may also represent increased blood flow along the 
lesion edge and this phenotype of ‘reactive hyper-perfusion’ has previously been 
described in Central Serous Chorioretinopathy. 19 
 
It has been proposed that APMPPE is an autolimited monophasic disease that 
can resolve spontaneously without any treatment, 1 and the role of systemic 
treatment is not clear in this disease. The fact that lesions in phase 1 can resolve 
without any morphological sequelae could provide the opportunity to assess the 
role of treatment vs. observation in APMPPE using features identified on multi-
modal imaging as end-points in future prospective studies. Importantly there is 
  
growing evidence that without treatment residual symptoms, such as 
paracentral scotomas, may persist. 20 Equally some of the bigger lesions showed 
an abnormal morphology of the choriocapillaris voids in the reperfused area in 
the OCT-A at the last follow-up available. This has also been described by 
others,18 and it could be the result of the different nature of the lesions or just a 
question of requiring longer follow-up to detect complete resolution in larger 
lesions. 
The sequence of events with SD-OCT, 12-14 FAF 12, 13, 15 and OCT-A 5, 7, 9, 16-18 has 
been previously described, but the correlation between different imaging 
technologies at the same time-point has not been reported for the three imaging 
modalities. A previous study correlating FAF and SD-OCT findings, found similar 
results to our study, with an initial hypoautofluorescence corresponding to the 
hyper-reflectance of the outer retinal layers on SD-OCT, probably due to a 
masking effect, with an increase of the hyperautofluorescence later when the 
OCT findings progress to disruption of the RPE layer. 12 
 
The authors acknowledge some important limitations in this study. Because of 
the retrospective nature of the study, patients did not have a standardised 
follow-up regime.  Sturcutre-function correlation would be interesting, 
particulary to determine if resolved lesions have any residual retinal dysfuction 
detectable. Clearly, larger cohorts of patients would be more beneficial, 
particulary for the purposes of quantitiatve analysis/correlation. 
 
In summary, the use of multimodal imaging for the follow-up of patients with 
APMPPE supports the increasing evidence of a choriocapillaritis as the 
  
underlying pathology in APMPPE, which may occur secondary to different 
aetiologies. Our study of the evolution of the disease shows resolution of 
choroidal ischaemia and an associated well defined sequence of imaging-related 
descriptors that can result in either permanent changes at the level of the RPE or 
resolution. The grading proposal we present has potential to provide an 
additional clinical tool to describe disease progression longitudinally, as well as 
permit the categorical assessment of effect of future therapeutic interventions 
for the treatment of APMPPE, however given the small numbers on this series 
and the retrospective nature of this study further prospective multi-centre 
studies are warranted for validation. 
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FIGURE LEGENDS 
 
 
Figure 1. Appearance of choroidal phase 1 lesions using different imaging 
modalities (left eye of Patient 3). One lesion of note is identified with a red circle. 
By FFA it is only evident in the early phase (A), disappearing in the late frames 
(B), however it is visible on ICGA across all frames (C and D). Equally the lesion is 
evident on OCT-A at the level of the choriocapillaris (E1), but no changes are 
seen on en face-OCT (F1) or SD-OCT B-scan at that location in either the 
horizontal (G1, red arrow) or vertical B-scans (H1, green arrow) or fundus 
autofluorescence (FAF) (I1). Five days from presentation the choroidal phase 
lesion is not seen in any of the imaging modalities, without any sequelae on FAF, 
en face-OCT or SD-OCT (E2-I2). 
 
Figure 2. Evolution of lesions in phase 2 (right eye of Patient 3). One lesion is 
identified with a red circle. It is hypofluorescent in the early phase of the FFA (A) 
with late hyperfluorescence (B), but persistent hypocyanescence across all 
frames (C and D) on ICGA. OCT-A revealed an absence of flow signal (E1) at the 
level of the choriocapillaris that progressively improved during follow-up (E2 
and E3). The en face-OCT confirms that the decrease in flow at the level of the 
choriocapilaris is not a consequence of signal attenuation secondary to hyper-
reflectivity of overlaying lesions (F). Similarly in horizontal (G) and vertical (H) 
sections of the SD-OCT through the lesion (red and green arrows, respectively) 
demonstrate that the findings evolve from an initial hyper-reflectivity at the level 
of the outer retina (G1 and H1) to a progressive retinal thinning with disruption 
  
of the RPE layer (G2-3 and H2-3). On FAF (I) lesions evolved from predominant 
hypoautofluorescence (I1) at baseline to central hyperautofluorescence (I2), but 
this subsequently gave way to a recurrence of hypoautofluorescence (I3). 
 
Figure 3. Evolution of Phase 1 lesion to a Phase 2 lesion and consecutive stages 
(left eye of Patient 3). The lesion is identified with a red circle. OCT-A (A1) 
discloses a small area of hypoperfusion, equally en face OCT shows mild 
hyporeflectivity at the level of the choriocapilaris (B1), but FAF and SD-OCT are 
essentially normal in the early stage (C1-E1). This choriocapillaris hypoperfusion 
identified on OCT-A had increased in size 10 days later (A2) with the lesion now 
identifiable on the SD-OCT in the horizontal (B2, red line) and vertical B-scans 
(C2, green line), as well as with FAF (D2) . 
 
 Figure 4. Choriocapillaris involvement exceeds detectable retinal structural 
changes (right eye of Patient 5). OCT-A image (A) at the level of the 
choriocapillaris (parallel horizontal red lines in B) revealed focal areas of 
hypoperfusion in the right eye of Patient 5. Corresponding SD-OCT scan (B) at 
the level of the green line on the OCT-A image (A1) revealed associated 
abnormalities in the outer retinal layers and RPE. The outer border of the area of 
hypoperfusion on OCT-A was seen to extend to a greater extent than the OCT B-
scan abnormalities (corresponding locations in A and B images are identified by 
vertical red lines). In the early evolution of the lesions the area of hypoperfusion 
in the OCT-A increased in size (A2), while the SD-OCT findings reveal qualitative 
outer retinal thinning (B2). With time the area of hypoperfusion at the level of 
the choriocapillaris improves (A3-4) and the thinning of the outer retina in SD-
  
OCT persists (B3-4). Corresponding en face-OCT at the level of the 
choriocapillaris at each time-point are presented in the bottom row (C1-4). 
